Combining Tanvex’s biosimilar development expertise and U.S. FDA-licensed commercial-scale facility in San Diego, California, with Bora’s extensive global CDMO capabilities, the alliance aims to provide comprehensive solutions to biologics CDMO customers around the world.

New Formulary Strategy Advances Biosimilar Adoption and Affordability

Biosimilar Solutions, Inc. will set up a facility in Aguadilla in OcyonBio's Campus in Puerto Rico to support the production of BSC0826.

Biosimilar Solutions, Inc. expects to complete the clinical study in 2022

At the heart of key challenges facing biologics laboratories today lies the volume and complexity of data created throughout the scientific process

Factors, such as growing incidence of cancer cases and lifestyle diseases globally, the cost-effectiveness of biosimilars over biologics, and strategic collaboration to develop new biosimilar drugs will increase the market growth during the forecast period.

The life sciences industry is evolving on a global scale. Shifting market demands, health care reforms and more stringent regulations are presenting new challenges to the industry at large. Taking a holistic approach to the challenges and opportunities that biomanufactureres face, Generis' American Biomanufacaturing Summit 2016 will present attendees with first-hand case studies, strategies and best practices to advance manufacturing excellence and drive innovation.

Indin an emerging market opens up as source for comparators, biosimilars in the clinical trial market. Sourcing Comparator, biosimilars from traditional markets such as US / EU have been an Achilles heel of the clinical trial industry for quite a while now.

As a world leader in cell line manufacturer and provider, Creative Diagnostics is now offering a portfolio of stable cell lines expressing biosimilars with its unique gene screening and amplification system.

Inaugural Biosimilars and Biobetters USA conference to take place Monday 7th - Tuesday 8th April 2014: Renaissance Woodbridge Hotel, Iselin, NJ